1. Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, Weigand MA. Diagnosis and management for urosepsis. Int J Urol. 2013;20:963–970. [PubMed] [Google Scholar]
2. Cove-Smith A, Almond MK. Management of urinary tract infections in the elderly. Trends in Urology Gynaecol Sex Health. 2007;12:31–34. [Google Scholar]
3. Reid G. Potential preventive strategies and therapies in urinary tract infection. World J Urol. 1999;17(6):359–363. [PubMed] [Google Scholar]
4. Head KA. Natural approaches to prevention and treatment of infections of the lower urinary tract. Altern Med Rev. 2008;13(3):227–244. [PubMed] [Google Scholar]
5. Gur S, Turgut-Balik D, Gur N. Antimicrobial activities and some fatty acids of turmeric, ginger root and linseed used in the treatment of infectious diseases. World J Agricultural Sci. 2006;2:439–442. [Google Scholar]
6. Ahmad I, Aqil F. In vitro efficacy of bioactive extracts of 15 medicinal plants against ESβL-producing multidrug-resistant enteric bacteria. Microbiol Res. 2007;162:264–275. [PubMed] [Google Scholar]
7. Sibanda T, Okoh AI. In vitro evaluation of the interactions between acetone extracts of Garcinia kola seeds and some antibiotics. Afr J Biotechnol. 2008;7:1672–1678. [Google Scholar]
8. Yarnell E. Botanical medicines for the urinary tract. World J Urol. 2002;20(5):285–293. [PubMed] [Google Scholar]
9. Amin AH, Subbaiah TV, Abbasi KM. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol. 1969;15(9):1067–1076. [PubMed] [Google Scholar]
10. Sahib AS, Mohammed IH, Hamdan SJ. Use of aqueous extract of corn silk in the treatment of urinary tract infection. J Intercult Ethnopharmacol. 2012;1(2):93–96. [Google Scholar]
11. Wang GQ, Xu T, Bu XM, Liu BY. Anti-inflammation effects of corn silk in a rat model of carrageenin induced pleurisy. Inflammation. 2012;35(3):822–827. [PubMed] [Google Scholar]
12. Pattanayak S, Das DC, Sinha NK, Parida S. Use of medicinal plants for the treatment of urinary tract infections: a study from Paschim Medinipur district, West Bengal, India. Int J Pharm Bio Sci. 2017;8(3):250–259. [Google Scholar]
13. Girach RD. Medicinal plants used by Kondha tribe of district Phulbani (Orissa) in eastern India. Ethnobot. 1992;4:53–66. [Google Scholar]
14. Nayak A, Das NB, Nanda B. Utility of some tribal drugs of Keonjhar and Similipal area. JTR Chem. 1998;5(2):53–59. [Google Scholar]
15. Brahmam M, Dhal NK, Saxena HO. Ethnobotanical studies among the Tanla of Malyagiri hills in Dhenkanal district Odisha, India. In: Jain SK, editor. Ethnobiology in Human welfare. New Delhi: Deep publication; 1996. pp. 393–396. [Google Scholar]
16. Satapathy KB, Brahmam M. Some medicinal plants used by the tribals of Sundargarh district, Orissa, India. In: Jain SK, editor. Ethnobiology in Human welfare. New Delhi: Deep publications; 1996. pp. 153–158. [Google Scholar]
17. Aminuddin GRD. Observations of the ethnobotany of the Bhunjia – a tribe of Sonabera plateau. Ethnobot. 1993;5:83–86. [Google Scholar]
18. Girach RD, Aminuddin AM, Mishra MK. Native phytotherapy among rural population of district Bhadrak, Orissa. In: Jain SK, editor. Ethnobiology in human welfare. New Delhi: Deep publications; 1996. pp. 162–164. [Google Scholar]
19. Dash SS, Mishra MK. Plant diversity and sustainable development in a tribal village eco-complex on the eastern ghats of Odisha. J Hum Ecol. 1999;10(5-6):415–419. [Google Scholar]
20. Bhattarai S, Chaudhary RP, Taylor RSL, Ghimire SK. Biological activities of some Nepalese medicinal plants used in treating bacterial infections in human beings. Nepal J Sci Tech. 2009;10:83–90. [Google Scholar]
21. Prachi CN, Kumar D, Kasana MS. Medicinal plants of Muzaffarnagar district used in treatment of urinary tract and kidney stones. Ind J Trad Med. 2009;8(2):191–195. [Google Scholar]
22. Hossan MS, Hanif A, Agarwala B, Sarwar MS, Karim M, Rahman MTU, Jahan R, Rahmatullah M. Traditional use of medicinal plants in Bangladesh to treat urinary tract infections and sexually transmitted diseases. Ethnobot Res Appl. 2010;8:61–74. [Google Scholar]
23. Revathi P, Parimelazhagan T. Traditional knowledge on medicinal plants used by the Irula tribe of Hasanur hills, Erode district, Tamil Nadu, India. Ethnobot Leaflets. 2010;2:4. [Google Scholar]
24. Darwish RM, Aburjai TA. Effect of ethnomedicinal plants used in folklore medicine in Jordan as antibiotic resistant inhibitors on Escherichia coli. BMC Complement Altern Med. 2010;10:9–16. [PMC free article] [PubMed] [Google Scholar]
25. Pereiraa RS, Sumitaa TC, Furlanb MR, Jorgec AOC, Uenod M. Antibacterial activity of essential oils on microorganisms isolated from urinary tract infection. Rev Saude Publica. 2004;38(2):1–3. [PubMed] [Google Scholar]
26. Sowmiya S, Soundarapandian P, Rajan S. Bioactive studies of Mangifera indica against bacteria isolated from urine samples. Curr Res J Biol Sci. 2009;1(3):139–143. [Google Scholar]
27. Sharma A, Chandraker S, Patel VK, Ramteke P. Antibacterial activity of medicinal plants against pathogens causing complicated urinary tract infections. Indian J Pharm Sci. 2009;71(2):136–139. [PMC free article] [PubMed] [Google Scholar]
28. Nweze EI, Eze EE. Justification for the use of Ocimum gratissimum L. in herbal medicine and its interaction with disc antibiotics. BMC Complement Altern Med. 2009;9:37. [PMC free article] [PubMed] [Google Scholar]
29. Yushau M, Onuorah FC, Murtala Y. In-vitro sensitivity pattern of some urinary tract isolates to Carica papaya extracts. Bayero J Pure Appl Sci. 2009;2(2):75–78. [Google Scholar]
30. Sosa V, Zunino P. Effect of Ibicella lutea on uropathogenic Proteus mirabilis growth, virulence, and biofilm formation. J Infect Dev Countries. 2009;3(10):762–770. [PubMed] [Google Scholar]
31. Kumar A, Sharma VK (2010) Antibacterial activity of allicin from Allium sativum against antibiotic resistant uropathogens. Int J Infect Dis 8(1)
32. Ravikumar S, Gnanadesigan M, Suganthi P, Ramalakshmi A. Antibacterial potential of chosen mangrove plants against isolated urinary tract infectious bacterial pathogens. Int J Med Medical Sci. 2010;2(3):94–99. [Google Scholar]
33. Poovendran P, Vidhya N, Murugan S. Antimicrobial activity of Coccinia grandis against biofilm and ESBL producing uropathogenic E. coli. Global J Pharmacol. 2011;5(1):23–26. [Google Scholar]
34. Khare RS, Karmakar S, Banerjee S, Nath G, Kundu S, Kundu K. Uropathogen resistant essential oils of Coleus aromaticus and Ocimum sanctum. Int J Pharm Sci Res. 2011;2(8):2168–2172. [Google Scholar]
35. Balasundaram A, Rathna Kumari P, John G, Selvakumar BN. Antimicrobial activity of the leaf extracts of two medicinal plants against MRSA (Methicilin resistant Staphylococcus aureus) from human urinary tract pathogens. Res J Microbiol. 2011;6(7):625–631. [Google Scholar]
36. Arun T, Rao CHP. Phytochemical screening and antibacterial activity of Moringa oleifera Lam. against Proteus mirabilis from urinary tract infected patients. Int J Pharm Tech Res. 2011;3(4):2118–2123. [Google Scholar]
37. Narayanan AS, Raja SS, Ponmurugan K, Kandekar SC, Natarajaseenivasan K, Maripandi A, Mandeel QA. Antibacterial activity of selected medicinal plants against multiple antibiotic resistant uropathogens: a study from Kolli Hills, Tamil Nadu, India. Benefic Microbes. 2011;2(3):235–243. [PubMed] [Google Scholar]
38. Vogel NW, Taschetto AP, Dallagnol R, Weidlich L, Ethur EM. Assessment of the antimicrobial effect of three plants used for therapy of community-acquired urinary tract infection in Rio Grande do Sul (Brazil) J Ethnopharmacol. 2011;137(3):1334–1336. [PubMed] [Google Scholar]
39. Khan MS, Ahmad I. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans. J Ethnopharmacol. 2012;140(2):416–423. [PubMed] [Google Scholar]
40. Kannan RR, Arumugam R, Anantharaman P. Chemical composition and antibacterial activity of Indian seagrasses against urinary tract pathogens. Food Chem. 2012;135(4):2470–2473. [PubMed] [Google Scholar]
41. Wojnicz D, Kucharska AZ, Sokol-Lętowska A, Kicia M, Tichaczek-Goska D. Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli. Urol Res. 2012;40(6):683–697. [PMC free article] [PubMed] [Google Scholar]
42. Reygaert W, Jusufi I. Green tea as an effective antimicrobial for urinary tract infections caused by Escherichia coli. Front Microbiol. 2013;4:162. [PMC free article] [PubMed] [Google Scholar]
43. Jagadeesan S, Natarajan V, Rajitha E, Vijayan S, Singaram S. Antibacterial activity of selective plant extracts against urinary tract infection causing organisms. J Microbiol Biotech Res. 2013;3(3):1–5. [Google Scholar]
44. Rawat S, Ishaq F, Khan A. Antimicrobial effect of drugs, medicinal plant extracts and essential oils against pathogenic bacteria causing urinary tract infection. Global J Biotech Biochem. 2013;8(1):15–24. [Google Scholar]
45. Poongothai P, Rajan S. Antibacterial properties of Mangifera indica flower extracts on uropathogenic Escherichia coli. Int J Curr Microbiol App Sci. 2013;2(12):104–111. [Google Scholar]
46. Manasa M, Kambar Y, Swamy HCS, Vivek MN, Kumar TNR, Kekuda TRP. Antibacterial efficacy of Pimenta dioica (Linn.) Merill and Anacardium occidentale L. against drug resistant urinary tract pathogens. J Appl Pharmaceut Sci. 2013;3(12):72–74. [Google Scholar]
47. Nadir M, Rasheed M, Sherwani SK, Kazmi SU, Ahmad VU. Chemical and antimicrobial studies on the essential oil from Salvia santolinifolia Boiss. Pak J Pharm Sci. 2013;26(1):39–52. [PubMed] [Google Scholar]
48. Rafsanjany N, Lechtenberg M, Petereit F, Hensel A. Antiadhesion as a functional concept for protection against uropathogenic Escherichia coli: In vitro studies with traditionally used plants with antiadhesive activity against uropathognic Escherichia coli. J Ethnopharmacol. 2013;145(2:591–597. [PubMed] [Google Scholar]
49. Dhanalakshmi J, Selvi S. Antibacterial activity of medicinal plants used against UTI (urinary tract infection) causing pathogens. Int J Res Sci. 2013;1(1):01–07. [Google Scholar]
50. Noormandi A, Dabaghzadeh F. Effects of green tea on Escherichia coli as a uropathogen. J Tradit Complement Med. 2014;5(1):15–20. [PMC free article] [PubMed] [Google Scholar]
51. Kavitha KS, Satish S. Antibacterial activity of seed extracts of Callistemon lanceolatus DC on uropathogenic bacteria. J Acute Med. 2014;4(1):6–12. [Google Scholar]
52. Vivek MN, Manasa M, Pallavi S, Swamy HCS, Kumar TNR, Kekuda TRP. Antibacterial activity of cashew (Anacardium occidentale L.) apple juice against antibiotic resistant urinary tract pathogens. World J Pharmaceu Sci. 2014;2(1):79–82. [Google Scholar]
53. Alshami I, Alharbi AE. Hibiscus sabdariffa extract inhibits in vitro biofilm formation capacity of Candida albicans isolated from recurrent urinary tract infections. Asian Pac J Trop Biomed. 2014;4(2):104–108. [PMC free article] [PubMed] [Google Scholar]
54. Jahan N, Khatoon R, Ahmad S. Evaluation of antibacterial potential of medicinal plant Cassia sophera against organisms causing urinary tract infection. Int J Pure App Biosci. 2015;3(2):450–455. [Google Scholar]
55. Tibyangye J, Okech MA, Nyabayo JM, Nakavuma JL. In vitro antibacterial activity of Ocimum suave essential oils against uropathogens isolated from patients in selected hospitals in Bushenyi District, Uganda. British Microbiology Research Journal. 2015;8(3):489–498. [PMC free article] [PubMed] [Google Scholar]
56. Ebana RUB, Edet UO, Ekanemesang UM, Etok CA, Ikon GM, Noble MK. Phytochemical screening and antimicrobial activity of three medicinal plants against urinary tract infection pathogens. Asian J Med Health. 2016;1(2):1–7. [Google Scholar]
57. Samanta P, Sinha NK. Antimicrobial activity of five traditionally used medicinal plants on bacterial infection of urinary tract. Int Res J Basic App Sci. 2016;1(2):24–28. [Google Scholar]
58. Aziz MA, Adnan M, Rahman H, Allah EFA, Hashem A, Alqarawi AA. Antibacterial activities of medicinal plants against multidrug resistant urinary tract pathogens. Pak J Bot. 2017;49(3):1185–1192. [Google Scholar]
59. Das S, Naik P, Panda P. Effect of Hemidesmus indicus R.Br. root extract on urinary tract infection causing bacteria. Int J Herbal Med. 2017;5(5):160–168. [Google Scholar]
60. Bodel PT, Cotran R, Kass EH. Cranberry juice and the antibacterial action of hippuric acid. J Lab Clin Med. 1959;54:881–888. [PubMed] [Google Scholar]
61. Lenter C (1991) Geigy scientific tables 18th Ed West Caldwell NJCIBA-Geigy.
62. Borukh IF, Kirbaba VI, Senchuk GV. Antimicrobial properties of cranberry. Vopr Pitan. 1972;31:82. [PubMed] [Google Scholar]
63. Kahn HD, Panariello VA, Saeli J, Sampson JR, Schwartz E. Effect of cranberry juice on urine. J Amer Diet Assoc. 1967;51:251–254. [PubMed] [Google Scholar]
64. Hamilton-Miller JMT. Reduction of bacteriuria and pyuria using cranberry juice. JAMA. 1994;272:588. [PubMed] [Google Scholar]
65. Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol. 1984;131(5):1013–1016. [PubMed] [Google Scholar]
66. Schmidt DR, Sobota AE. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios. 1988;55(224-225):173–181. [PubMed] [Google Scholar]
67. Shmuely H, Ofek I, Weiss EI, Rones Z, Houri-Haddad Y. Cranberry components for the therapy of infectious disease. Curr Opin Biotechnol. 2012;23(2):148–152. [PubMed] [Google Scholar]
68. Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eukaryotic cells. Antimicrob Agents Chemother. 1989;33:92–98. [PMC free article] [PubMed] [Google Scholar]
69. Guay DR. Cranberry and urinary tract infections. Drugs. 2009;69(7):775–807. [PubMed] [Google Scholar]
70. Howell AB, Vorsa N, Marderosian AD, Foo LY. Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med. 1998;339:1085–1086. [PubMed] [Google Scholar]
71. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochem. 2005;66(18):2281–2291. [PubMed] [Google Scholar]
72. Greenberg JA, Sara J, Newmann MD, Howell AB. Consumption of sweetened dried cranberries versus unsweetened raisins for inhibition of uropathogenic Escherichia coli adhesion in human urine: a pilot study. J Altern Complement Med. 2005;11(5):875–878. [PubMed] [Google Scholar]
73. Di Martino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, et al. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. World J Urol. 2006;24(1):21–27. [PubMed] [Google Scholar]
74. Valentova K, Stejskal D, Bednar P, Vostalova J, Cihalik C, Vecerova R, et al. Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: a pilot double-blind placebo-controlled trial. J Agric Food Chem. 2007;55(8):3217–3224. [PubMed] [Google Scholar]
75. Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapleton AE. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vagin*l epithelial cells. J Urol. 2007;177(6):2357–2360. [PMC free article] [PubMed] [Google Scholar]
76. Lavigne JP, Bourg G, Combescure C, Botto H, Sotto A. In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clin Microbiol Infect. 2008;14(4):350–355. [PMC free article] [PubMed] [Google Scholar]
77. Pinzon-Arango PA, Liu Y, Camesano TA. Role of cranberry on bacterial adhesion forces and implications for Escherichia coli-uroepithelial cell attachment. J Med Food. 2009;12(2):259–270. [PubMed] [Google Scholar]
78. Lee YL, Najm WI, Owens J, Thrupp L, Baron S, Shanbrom E, et al. Antimicrobial activity of urine after ingestion of cranberry: a pilot study. Evid Based Complement Alternat Med. 2010;7(2):227–232. [PMC free article] [PubMed] [Google Scholar]
79. Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010;10:94. [PMC free article] [PubMed] [Google Scholar]
80. Lavigne JP, Vitrac X, Bernard L, Bruyere F, Sotto A. Propolis can potentialise the anti-adhesion activity of proanthocyanidins on uropathogenic Escherichia coli in the prevention of recurrent urinary tract infections. BMC Res Notes. 2011;4:522–528. [PMC free article] [PubMed] [Google Scholar]
81. Rane HS, Bernardo SM, Howell AB, Lee SA. Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms. J Antimicrob Chemother. 2014;69(2):428–436. [PMC free article] [PubMed] [Google Scholar]
82. Nicolosi D, Tempera G, Genovese C, Furneri PM. Anti-adhesion activity of A2-type proanthocyanidins (a cranberry major component) on uropathogenic E. coli and P. mirabilis strains. Antibiotics (Basel) 2014;3(2):143–154. [PMC free article] [PubMed] [Google Scholar]
83. Ulrey RK, Barksdale SM, Zhou W, van Hoek ML. Cranberry proanthocyanidins have anti-biofilm properties against Pseudomonas aeruginosa. BMC Complement Altern Med. 2014;14:499. [PMC free article] [PubMed] [Google Scholar]
84. Sun J, Marais JPJ, Khoo C, LaPlante K, Vejborg RM, Givskov M, Tolker-Nielsen T, Seeram NP, Rowleya DC. Cranberry (Vaccinium macrocarpon) oligosaccharides decrease biofilm formation by uropathogenic Escherichia coli. J Funct Foods. 2015;17:235–242. [PMC free article] [PubMed] [Google Scholar]
85. de Llano DG, Esteban-Fernandez A, Sanchez-Patan F, Martín-Álvarez PJ, Moreno-Arribas MV, Bartolome B. Anti-adhesive activity of cranberry phenolic compounds and their microbial-derived metabolites against uropathogenic Escherichia coli in bladder epithelial cell cultures. Int J Mol Sci. 2015;16(6):12119–12130. [PMC free article] [PubMed] [Google Scholar]
86. Rafsanjany N, Senker J, Brandt S, Dobrindt U, Hensel A. In vivo consumption of cranberry exerts ex vivo antiadhesive activity against fimH-dominated uropathogenic Escherichia coli: a combined in vivo, ex vivo, and in vitro study of an extract from Vaccinium macrocarpon. J Agric Food Chem. 2015;63(40):8804–8818. [PubMed] [Google Scholar]
87. Jensen HD, Struve C, Christensen SB, Krogfelt KA. Cranberry juice and combinations of its organic acids are effective against experimental urinary tract infection. Front Microbiol. 2017;8:542. [PMC free article] [PubMed] [Google Scholar]
88. Cimolai N, Cimolai T. The cranberry and the urinary tract. Eur J Clin Microbiol Infect Dis. 2007;26(11):767–776. [PubMed] [Google Scholar]
89. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAM. 1994;271(10):751–754. [PubMed] [Google Scholar]
90. Foda MM, Middlebrook PF, Gatfield CT, Potvin G, Wells G, Schillinger JF. Efficacy of cranberry in prevention of urinary tract infection in a susceptible pediatric population. Can J Urol. 1995;2(1):98–102. [PubMed] [Google Scholar]
91. Walker EB, Barney DP, Mickelsen JN, Walton RJ, Mickelsen RA., Jr Cranberry concentrate: UTI prophylaxis. J Fam Pract. 1997;45(2):167–168. [PubMed] [Google Scholar]
92. Schlager TA, Anderson S, Trudell J, Hendley JO. Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatr. 1999;135(6):698–702. [PubMed] [Google Scholar]
93. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322(7302):1571. [PMC free article] [PubMed] [Google Scholar]
94. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol. 2002;9(3):1558–1562. [PubMed] [Google Scholar]
95. McGuinness SD, Krone R, Metz LM. A double-blind, randomized, placebo-controlled trial of cranberry supplements in multiple sclerosis. J Neurosci Nursing. 2002;34(1):4–7. [Google Scholar]
96. Waites KB, Canupp KC, Armstrong S, DeVivo MJ. Effect of cranberry extract on bacteriuria and pyuria in persons with neurogenic bladder secondary to spinal cord injury. J Spinal Cord Med. 2004;27(1):35–40. [PubMed] [Google Scholar]
97. Linsenmeyer TA, Harrison B, Oakley A, Kirshblum S, Stock JA, Millis SR. Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. A prospective, double-blinded, placebo-controlled, crossover study. J Spinal Cord Med. 2004;27(1):29–34. [PubMed] [Google Scholar]
98. McMurdo ME, Bissett LY, Price RJ, Phillips G, Crombie IK. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial. Age Ageing. 2005;34(3):256–261. [PubMed] [Google Scholar]
99. Lee BB, Haran MJ, Hunt LM, Simpson JM, Marial O, Rutkowski SB, et al. Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord. 2007;45(8):542–550. [PubMed] [Google Scholar]
100. Wing DA, Rumney PJ, Preslicka CW, Chung JH. Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. J Urol. 2008;180(4):1367–1372. [PMC free article] [PubMed] [Google Scholar]
101. Hess MJ, Hess PE, Sullivan MR, Nee M, Yalla SV. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord. 2008;46(9):622–626. [PubMed] [Google Scholar]
102. McMurdo ME, Argo I, Phillips G, Daly F, Davey P. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J Antimicrob Chemother. 2009;63(2):389–395. [PMC free article] [PubMed] [Google Scholar]
103. Ferrara P, Romaniello L, Vitelli O, Gatto A, Serva M, Cataldi L. Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scand J Urol Nephrol. 2009;43(5):369–372. [PubMed] [Google Scholar]
104. Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis. 2011;52(1):23–30. [PMC free article] [PubMed] [Google Scholar]
105. Salo J, Uhar M, Helminen M, Korppi M, Nieminen T, Pokka T, Kontiokari T. Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo-controlled trial. Clin Infect Dis. 2012;54(3):340–346. [PubMed] [Google Scholar]
106. Bonetta A, Di Pierro F. Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma. Cancer Manag Res. 2012;4:281–286. [PMC free article] [PubMed] [Google Scholar]
107. Stapleton AE, Dziura J, Hooton TM, Cox ME, Yarovaya YY, Chen S, Gupta K. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc. 2012;87(2):143–150. [PMC free article] [PubMed] [Google Scholar]
108. Bianco L, Perrelli E, Towle V, Ness PHV, Mehta MJ. Pilot randomized controlled dosing study of cranberry capsules for reduction of bacteriuria plus pyuria in female nursing home residents. J Am Geriatr Soc. 2012;60(6):1180–1181. [PMC free article] [PubMed] [Google Scholar]
109. Burleigh AE, Benck SM, McAchran SE, Reed JD, Krueger CG, Hopkins WJ. Consumption of sweetened, dried cranberries may reduce urinary tract infection incidence in susceptible women – a modified observational study. Nutr J. 2013;12:139. [PMC free article] [PubMed] [Google Scholar]
110. Caljouw MAA, van den Hout WB, Putter H, Achterberg WP, Cools HJM, Gussekloo J. Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: a double-blind randomized placebo-controlled trial in long-term care facilities. J Am Geriatr Soc. 2014;62(1):103–110. [PMC free article] [PubMed] [Google Scholar]
111. Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol. 2015;213(2):194. [PMC free article] [PubMed] [Google Scholar]
112. Dieter AA. Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation. Evid Based Med. 2015;20(4):137. [PubMed] [Google Scholar]
113. Vostalova J, Vidlar A, Simanek V, Galandakova A, Kosina P, Vacek J, Vrbkova J, Zimmermann BF, Ulrichova J, Student V. Are high proanthocyanidins key to Cranberry efficacy in the prevention of recurrent urinary tract infection? Phytother Res. 2015;10:1559–1567. [PubMed] [Google Scholar]
114. Maki KC, Kaspar KL, Khoo C, Derrig LH, Schild AL, Gupta K. Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection. Am J Clin Nutr. 2016;103:1434–1442. [PubMed] [Google Scholar]
115. Amalaradjou MA, Narayanan A, Baskaran SA, Venkitanarayanan K. Antibiofilm effect of trans-cinnamaldehyde on uropathogenic Escherichia coli. J Urol. 2010;184(1):358–363. [PubMed] [Google Scholar]
116. Amalaradjou MA, Narayanan A, Venkitanarayanan K. Trans-cinnamaldehyde decreases attachment and invasion of uropathogenic Escherichia coli in urinary tract epithelial cells by modulating virulence gene expression. J Urol. 2011;185(4):1526–1531. [PubMed] [Google Scholar]
117. Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti-Escherichia coli activity of cranberry and blueberry juices. NEJM. 1991;324:1599. [PubMed] [Google Scholar]
118. Schindler G, Patzak U, Brinkhaus B, von Niecieck A, Wittig J, Krahmer N, Glockl I, Veit M. Urinary excretion and metabolism of arbutin after oral administration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans. J Clin Pharmacol. 2002;42(8):920–927. [PubMed] [Google Scholar]
119. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001;30:49–52. [PubMed] [Google Scholar]
120. Hutt P, Shchepetova J, Loivukene K, Kullisaar T, Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero and uropathogens. J Appl Microbiol. 2006;100(6):1324–1332. [PubMed] [Google Scholar]
121. Kontiokari T, Laitinen J, Jarvi L, Pokka T, Sundqvist K, Uhari M. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr. 2003;77:600–604. [PubMed] [Google Scholar]
122. Chan RCY, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun. 1985;47(1):84–89. [PMC free article] [PubMed] [Google Scholar]
123. Reid G, Chan RC, Bruce AW, Costerton JW. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infect Immun. 1985;49(2):320–324. [PMC free article] [PubMed] [Google Scholar]
124. Liu YH, Ho CY, Huang CC, Tsai CC. Inhibitory effect of lactic acid bacteria on uropathogenic Escherichia coli-induced urinary tract infections. J Prob Health. 2016;4(2):144–150. [Google Scholar]
125. Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science. 1997;276:607–611. [PubMed] [Google Scholar]
126. Langermann S, Möllby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis. 2000;181:774–778. [PubMed] [Google Scholar]
127. Asadi Karam MR, Oloomi M, Mahdavi M, Habibi M, Bouzari S. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine. 2013;31:1210–1216. [PubMed] [Google Scholar]
128. Li X, Erbe JL, Lockatell CV, Johnson DE, Jobling MG, Holmes RK, Mobley HLT. Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis. Infect Immun. 2004;72:7306–7310. [PMC free article] [PubMed] [Google Scholar]
129. O’Hanley P, Lalonde G, Ji G. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an α-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect Immun. 1991;59:1153–1161. [PMC free article] [PubMed] [Google Scholar]
130. Kosikowska P, Berlicki L. Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. Expert Opin Ther Pat. 2011;21:945–957. [PubMed] [Google Scholar]
131. Pinkner JS, Remaut H, Buelens F, Miller E, Aberg V, Pemberton N, et al. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc Natl Acad Sci USA. 2006;103:17897–17902. [PMC free article] [PubMed] [Google Scholar]
132. Cusumano CK, Pinkner JS, Han Z, Greene SE, Ford BA, Crowley JR, Henderson JP, Janetka JW, Hultgren SJ. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med. 2011;3:109–115. [PMC free article] [PubMed] [Google Scholar]
133. Kostakioti M, Hadjifrangiskou M, Hultgren SJ. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med. 2013;3:a010306. [PMC free article] [PubMed] [Google Scholar]
134. Koradia P, Kapadia S, Trivedi Y, Chanchu G, Harper A. Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women: a controlled pilot study. Exp Rev Anti-Infect Therapy. 2019;17(9):733–740. [PubMed] [Google Scholar]
135. Dotis J, Stabouli S, Pavlaki A, Papachristou F, Printza N. Cranberry standardized capsules may prevent recurrences of urinary tract infections in children. Clin Pediatr. 2018;1:1007. [Google Scholar]
136. Das S, Panigrahi S, Panda P. Antiurobacterial activity of Punica granatum L. seed extract. European J Med Plants. 2018;22(2):1–12. [Google Scholar]
137. Das S, Sahoo KR, Parida B. Bactericidal activity of Hemidesmus indicus R.Br. root extract against clinically isolated uropathogens. J Med Plant Studies. 2018;6(6):180–192. [Google Scholar]
